Epidarex Capital

Epidarex Capital

Bethesda, Marylandepidarex.com

Overview

Epidarex Capital is a transatlantic venture firm that invests in early-stage, high-growth life science companies in under-ventured markets. Epidarex focuses on providing risk capital and expertise to create, support and build young companies, including spinouts, from leading research institutions in both established and emerging life science hubs. The fund's international management team has a track record of successfully partnering with top scientists and entrepreneurs to develop highly innovative products for the global healthcare market.

Year Founded

2010

Portfolio Companies

17

Investments

CompanyDateStageLead
NodTheraApr 2025Series DCo-investor
Harness TherapeuticsJan 2025VC RoundCo-investor
EpsilogenSep 2024Series B ExtensionLead
Kodikaz Therapeutic Solutions Inc.May 2024VC RoundCo-investor
TheolyticsApr 2024VC RoundCo-investor

Key People

Kyparissia Sirinakis

Co-Founder Managing Partner

Sinclair Dunlop

Managing Partner

Henning Steinhagen

Venture Partner

Lori Gough

Partner

Peter Finan

Partner

Matthew Miessau

Principal

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBethesda, Maryland
Year Founded2010

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.